GENEVA, May 6 -- JANSSEN PHARMACEUTICALS, INC. (1125 Trenton-Harbourton Rd.Titusville, NJ 08560), AC IMMUNE SA (EPFL Innovation ParkBuilding BCH-1015 Lausanne) filed a patent application (PCT/US2024/052881) for "METHOD OF TREATING PRECLINICIAL ALZHEIMER'S DISEASE" on Oct 24, 2024. With publication no. WO/2025/090815, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): STREFFER, Johannes (c/o AC Immune SAEPFL Innovation Park, Building BCH-1015 Lausanne), STEUKERS, Lennert (c/o Janssen Pharmaceutical NVTurnhoutseweg 302340 Beer...